YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role

YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role

Primary liver cancer comprises a diverse group of liver tumors. The heterogeneity of these tumors is seen as one of the obstacles to finding an effective therapy. The Hippo pathway, with its downstream transcriptional co-activator Yes-associated protein (YAP) and transcriptional co-activator with PD...

Whakaahuatanga katoa

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua:	Matthias Van Haele, Iván M. Moya, Ruçhan Karaman, Guy Rens, J. Snoeck, Olivier Govaere, Frederik Nevens, Chris Verslype, Baki Topal, Diethard Monbaliu, Georg Halder, Tania Roskams
Hōputu:	Artigo
Reo:	Ingarihi
I whakaputaina:	2019
Urunga tuihono:	https://doi.org/10.3390/ijms20030638 https://www.mdpi.com/1422-0067/20/3/638/pdf?version=1549024629
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite

YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role
mā: Van Haele, Matthias, me ētahi atu.
I whakaputaina: (2019)

Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice
mā: Iván M. Moya, me ētahi atu.
I whakaputaina: (2019)

High‐throughput sequencing identifies aetiology‐dependent differences in ductular reaction in human chronic liver disease
mā: Olivier Govaere, me ētahi atu.
I whakaputaina: (2018)

The PDGFRα-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma
mā: Olivier Govaere, me ētahi atu.
I whakaputaina: (2017)

Human Liver Regeneration: An Etiology Dependent Process
mā: Van Haele, Matthias, me ētahi atu.
I whakaputaina: (2019)

Human Liver Regeneration: An Etiology Dependent Process
mā: Matthias Van Haele, me ētahi atu.
I whakaputaina: (2019)

YAP/TAZ Orchestrate VEGF Signaling during Developmental Angiogenesis
mā: Xiaohong Wang, me ētahi atu.
I whakaputaina: (2017)

Regeneration Defects in Yap and Taz Mutant Mouse Livers Are Caused by Bile Duct Disruption and Cholestasis
mā: Elisabeth Verboven, me ētahi atu.
I whakaputaina: (2020)

Cell Junctions in Hippo Signaling
mā: Karaman, Ruchan, me ētahi atu.
I whakaputaina: (2018)

Cell Junctions in Hippo Signaling
mā: Ruçhan Karaman, me ētahi atu.
I whakaputaina: (2017)

Age Matching of Elderly Liver Grafts With Elderly Recipients Does Not Have a Synergistic Effect on Long-term Outcomes When Both Are Carefully Selected
mā: Gilbo, Nicholas, me ētahi atu.
I whakaputaina: (2019)

YAP/TAZ at the roots of cancer
mā: Zanconato, Francesca, me ētahi atu.
I whakaputaina: (2016)

YAP/TAZ at the Roots of Cancer
mā: Francesca Zanconato, me ētahi atu.
I whakaputaina: (2016)

Roles of YAP/TAZ in ferroptosis
mā: Suchitra Magesh, me ētahi atu.
I whakaputaina: (2022)

Septuagenarian and Octogenarian Donors Provide Excellent Liver Grafts for Transplantation
mā: Tom Darius, me ētahi atu.
I whakaputaina: (2012)

The emerging roles of YAP and TAZ in cancer
mā: Moroishi, Toshiro, me ētahi atu.
I whakaputaina: (2015)

DNA binding partners of YAP/TAZ
mā: Kim, Min-Kyu, me ētahi atu.
I whakaputaina: (2018)

Hippo-YAP/TAZ signaling in angiogenesis
mā: Park, Jeong Ae, me ētahi atu.
I whakaputaina: (2018)

YAP/TAZ as therapeutic targets in cancer
mā: Zanconato, Francesca, me ētahi atu.
I whakaputaina: (2016)

Mechanobiology of YAP and TAZ in physiology and disease
mā: Panciera, Tito, me ētahi atu.
I whakaputaina: (2017)

The emerging role of YAP/TAZ in mechanotransduction
mā: Mohri, Zahra, me ētahi atu.
I whakaputaina: (2017)

YAP and TAZ regulate cell volume
mā: Perez-Gonzalez, Nicolas A., me ētahi atu.
I whakaputaina: (2019)

Mechanisms of YAP/TAZ transcriptional control
mā: Battilana, Giusy, me ētahi atu.
I whakaputaina: (2021)

YAP/TAZ in Bone and Cartilage Biology
mā: Zarka, Mylène, me ētahi atu.
I whakaputaina: (2022)

YAP/TAZ as therapeutic targets in cancer
mā: Francesca Zanconato, me ētahi atu.
I whakaputaina: (2016)

Interplay between YAP/TAZ and Metabolism
mā: Ja Hyun Koo, me ētahi atu.
I whakaputaina: (2018)

Mechanobiology of YAP and TAZ in physiology and disease
mā: Tito Panciera, me ētahi atu.
I whakaputaina: (2017)

The emerging roles of YAP and TAZ in cancer
mā: Toshiro Moroishi, me ētahi atu.
I whakaputaina: (2015)

DNA binding partners of YAP/TAZ
mā: Min‐Kyu Kim, me ētahi atu.
I whakaputaina: (2018)

Hippo-YAP/TAZ signaling in angiogenesis
mā: Jeong Ae Park, me ētahi atu.
I whakaputaina: (2018)

YAP/TAZ in Bone and Cartilage Biology
mā: Mylène Zarka, me ētahi atu.
I whakaputaina: (2022)

Mechanisms of YAP/TAZ transcriptional control
mā: Giusy Battilana, me ētahi atu.
I whakaputaina: (2021)

Nuclear Import and Export of YAP and TAZ
mā: Michael Kofler, me ētahi atu.
I whakaputaina: (2023)

YAP and TAZ regulate cell volume
mā: Nicolas A. Perez-Gonzalez, me ētahi atu.
I whakaputaina: (2019)

The emerging role of YAP/TAZ in mechanotransduction
mā: Zahra Mohri, me ētahi atu.
I whakaputaina: (2017)

The PDGFRα-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma
mā: Govaere, O, me ētahi atu.
I whakaputaina: (2017)

RNA-sequencing-based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers
mā: Ceulemans, An, me ētahi atu.
I whakaputaina: (2017)

TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex
mā: Merritt, Nicole, me ētahi atu.
I whakaputaina: (2021)

TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex
mā: Nicole Merritt, me ētahi atu.
I whakaputaina: (2021)

The Impact of Liver Transplantation after Surgical Treatment of Hepatocellular Carcinoma
mā: Topal, Halit, me ētahi atu.
I whakaputaina: (2014)